A randomised, double-blind, placebo controlled trial of the effect versus placebo of twice daily doses of mannitol (80mg) for one week on nasal mucociliary clearance in healthy adults and adults with allergic rhinitis or chronic sinusitis.

Trial Profile

A randomised, double-blind, placebo controlled trial of the effect versus placebo of twice daily doses of mannitol (80mg) for one week on nasal mucociliary clearance in healthy adults and adults with allergic rhinitis or chronic sinusitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jun 2016

At a glance

  • Drugs Mannitol (Primary) ; Mannitol (Primary)
  • Indications Allergic rhinitis; Chronic sinusitis
  • Focus Therapeutic Use
  • Acronyms MCC123
  • Most Recent Events

    • 08 Jun 2016 Status changed from recruiting to completed.
    • 15 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top